Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?-Reference-Cited by-同舟云学术

Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?

Published:2011-07-25 Issue:11 Volume:70 Page:1914-1920
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Annals of the Rheumatic Diseases

Author:

Strangfeld A.,Eveslage M.,Schneider M.,Bergerhausen H. J.,Klopsch T.,Zink A.,Listing J.

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Cited by 309 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tuberculin skin test repetition after TNF-α inhibitors in patients with chronic inflammatory arthritis: a long-term retrospective cohort in endemic area;Advances in Rheumatology;2024-09-13

2. Sicherheit und Wirksamkeit der Therapie der rheumatoiden Arthritis im Alter: Was sagen Register- und Routinedaten?;Aktuelle Rheumatologie;2024-08-27

3. Machine learning prediction and explanatory models of serious infections in patients with rheumatoid arthritis treated with tofacitinib;Arthritis Research & Therapy;2024-08-27

4. Safety and Efficacy of Upadacitinib in Patients with Rheumatoid Arthritis Refractory to Biologic DMARDs: Results Through Week 216 from the SELECT-CHOICE Study;Rheumatology and Therapy;2024-07-20

5. Effect of traditional therapeutics on prevalence and clinical outcomes of coronavirus disease 2019 in Chinese patients with autoimmune diseases;Journal of Translational Autoimmunity;2024-06